![](/img/cover-not-exists.png)
The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trial
Bjarnason, Georg A., Knox, Jennifer J., Kollmannsberger, Christian K., Soulieres, Denis, Ernst, D. Scott, Zalewski, Pawel, Canil, Christina M., Winquist, Eric, Hotte, Sebastien J., North, Scott A., HeVolume:
108
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2018.12.006
Date:
February, 2019
File:
PDF, 1.24 MB
english, 2019